Sponsor:
Amgen
Code:
NCT06150781
Conditions
Migraine
Eligibility Criteria
Sex: Female
Age: 18 - 70+
Healthy Volunteers: Accepted
Interventions
erenumab-aooe
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-18. This information was provided to ClinicalTrials.gov by Amgen on 2025-11-04.